Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3
Pre-publication versions of this article are available by contacting email@example.com.
|30 Mar 2007||Submitted||Original manuscript|
|1 May 2007||Reviewed||Reviewer Report - Katherine Schaefer|
|10 May 2007||Reviewed||Reviewer Report - Stephen Safe|
|15 Jun 2007||Reviewed||Reviewer Report - Michael Kilgore|
|30 Jul 2007||Author responded||Author comments - Maria Jasnis|
|Resubmission - Version 2|
|30 Jul 2007||Submitted||Manuscript version 2|
|29 Aug 2007||Reviewed||Reviewer Report - Michael Kilgore|
|4 Sep 2007||Reviewed||Reviewer Report - Katherine Schaefer|
|1 Oct 2007||Reviewed||Reviewer Report - Stephen Safe|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|9 Jan 2008||Reviewed||Reviewer Report - Stephen Safe|
|5 Feb 2008||Author responded||Author comments - Joseph Crossland|
|Resubmission - Version 5|
|5 Feb 2008||Submitted||Manuscript version 5|
|8 Feb 2008||Editorially accepted|
|8 Feb 2008||Article published||10.1186/1471-2407-8-47|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.